Lugen Zuo

机构：Bengbu Medical College, First Affiliated Hospital of Bengbu Medical College · ORCID：0000-0002-8300-0860

发表论文 119 篇 · 总被引 1864 次 · h-index 23

代表论文

• Ginkgetin improved experimental colitis by inhibiting intestinal epithelial cell apoptosis through EGFR/PI3K/AKT signaling (2024 · The FASEB Journal · 被引 21)
• Sakuranetin ameliorates experimental colitis in a gut microbiota-dependent manner (2025 · Phytomedicine · 被引 14)
• Magnolin inhibits intestinal epithelial cell apoptosis alleviating Crohn's disease-like colitis by suppressing the PI3K/AKT signalling pathway (2024 · International Immunopharmacology · 被引 12)
• Sophoricoside improved Crohn's disease-like colitis by inhibiting intestinal epithelial cell apoptosis through PI3K/AKT signaling (2024 · International Immunopharmacology · 被引 11)
• Cynaroside ameliorates TNBS-induced colitis by inhibiting intestinal epithelial cell apoptosis via the PI3K/AKT signalling pathway (2025 · Frontiers in Pharmacology · 被引 10)
• Sclareol protected against intestinal barrier dysfunction ameliorating Crohn's disease-like colitis via Nrf2/NF-B/MLCK signalling (2024 · International Immunopharmacology · 被引 9)